Skip to content

Dialogical Family Guidance for Neurodevelopmental Disorders

Dialogical Family Guidance in Families With a Child With Neurodevelopmental Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04892992
Acronym
DFG
Enrollment
50
Registered
2021-05-19
Start date
2016-01-06
Completion date
2018-12-31
Last updated
2021-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Family Dynamics

Keywords

Dialogical family guidance, family health, neurodevelopmental disorders

Brief summary

Previous studies have highlighted the need to offer targeted effective interventions to strengthen the wellbeing of all family members in families with children with neurodevelopmental disorders (NDD). Interventions for this target group requires development and research. A new family intervention, Dialogical Family Guidance (DFG) was tested in this study. All families received DFG intervention ( 6 meetings ).

Detailed description

Previous studies have highlighted the need to offer targeted effective interventions to strengthen the wellbeing of all family members in families with children with neurodevelopmental disorders (NDD). Interventions for this target group requires development and research. A new family intervention, Dialogical Family Guidance (DFG) was tested in this study. Fifty families of children with NDD were randomized into two intervention groups. Intervention group I were delivered DFG immediately, and Intervention group II were delivered DFG after three months. Family functionality, health and support (FAFHES), SDQ and the 5-15-questionnaire and DFG parent questionnaires were used to collect data at baseline, after three and six months. Fifty families were invited to the study. Thirty-four families completed the study. A comparison were made between Intervention group I and II.

Interventions

BEHAVIORALDFG

Sponsors

Diana Cavonius-Rintahaka
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Intervention group I were delivered DFG immediately, and Intervention group II were delivered DFG after three months.

Intervention model description

Intervention group I were delivered DFG immediately and Intervention group II were delivered DFG after three months.

Eligibility

Sex/Gender
ALL
Age
5 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* clinical neurodevelopmental disorder diagnosis (eg ADHD, ASD, tics, language disorders) * the child is aged between 4-16 years * parent have adequate Finnish language skills * parents are biological parents or step-parents of the child

Exclusion criteria

* the child is under 4 or over 16 years old * parents do not have adequate Finnish language skills

Design outcomes

Primary

MeasureTime frameDescription
The Family Function, Health and Social Support - scale (FAFHES)Baseline measure before DFG family intervention startsThe FAFHES questionnaire contains three sections; family functionality (19 items), family health (23 items), and family support provided by professionals (21 items). All the items are measured on a Likert scale ranging from 1-6 (I disagree totally, I disagree, I disagree somewhat, I agree somewhat, I agree, I agree totally). Family functionality, family health and family support were seen as poor if the median was 1.00-2.7, moderate if it was 2.8-4.5, and good if it was 4.6-6.0.45. Parent questionnaire. 1=I totally disagree.....6=I absolutely agree. Higher scores mean worse outcome.
The Family Function, Health and Social Support Scale (FAFHES)3 months after baseline measure, when intervention is finished. Change is being assessed.The FAFHES questionnaire contains three sections; family functionality (19 items), family health (23 items), and family support provided by professionals (21 items). All the items are measured on a Likert scale ranging from 1-6 (I disagree totally, I disagree, I disagree somewhat, I agree somewhat, I agree, I agree totally). Family functionality, family health and family support were seen as poor if the median was 1.00-2.7, moderate if it was 2.8-4.5, and good if it was 4.6-6.0.45. Parent questionnaire. 1=I totally disagree.....6=I absolutely agree. Higher scores mean worse outcome.

Secondary

MeasureTime frameDescription
The Dialogical Family Guidance (DFG) - questionnaire3 months after baseline measure, when intervention is finished.The DFG-questionnaire was developed for this study to obtain information and parents' experiences about the DFG family intervention. The questionnaire include 14 items. Questions about the content and recommendation of DFG sessions were for example: Did you get practical tips for daily life? (1= yes absolutely….5=not at all) and Would you recommend DFG to other parents? (1=yes absolutely….4=no). The following semi-structured open-ended question was included in the DFG-questionnaire: Could you describe your experiences, comments or/and ideas about how to improve DFG? Parents filled the questionnaire after completing the DFG process (six meetings). Most questions were opinions about DFG, but when questions about Did you get help from DFG? 1=very much.... 5=not at all
The Strengths and Difficulties Questionnaire (SDQ)Baseline measure before DFG family intervention startsSDQ measures the changes in child's behavior. 25 items with 3-point likert scale; Not true (0)- Somewhat true (1) - Certainly true (2). Parent questionnaire. Higher scores mean worse outcome considering the child with neurodevelopmental disorder.Highest scores 50 - lowest 0. Total score16-40 = high risk for abnormalities.
Parent Questionnaire for Evaluation of Development and Behaviour in 5-15-year old Children, 5-15 (FTF, Five - to - Fifteen)Baseline measure before DFG family intervention startsParent Questionnaire for evaluation of development and behaviour in 5-15-year old children. 181 items. Three point likert scale; Not true (0) - Somewhat true (1)- Certainly true (2). Higher scores mean worse outcome considering the child. 0-13 scores normal and 17-40 scores mean abnormal result/abnormal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026